Why We Should Ban PBM Rebates
February 13, 2024 — This policy brief explains how pharmacy benefit managers weaponize rebates to raise prices for patients, debunks myths surrounding their purpose and use, and details how policymakers can eliminate them.
The Dirty Secret of Drug Shortages
October 19, 2023 — This brief explains the medical shortage problem and the multiple roles that GPOs play in medical supply markets. It then outlines a series of common-sense reforms to rein them in.
The Costs of Pharma Cheating
May 16, 2023 — "The Costs of Pharma Cheating" examines one central driver of rising prescription drug prices: the illegal and anticompetitive tactics used by the pharmaceutical industry to perpetuate monopolies—in the form of government-backed patents over brand drugs—and block competition from more affordable generic drugs.
The Harms of Hospital Mergers and How to Stop Them
April 26, 2023 — "The Harms of Hospital Mergers and How to Stop Them" lays out how hospital consolidation raise prices and lowers quality of care for patients, reduces access, and dampens wages and benefits for hospital staff, along with how policymakers can take action.
Statement for the Record re: “Building Transparency and Accountability to Pharmacy Benefit Managers”
February 16, 2023 — Economic Liberties submitted this statement for the record to Senator Cantwell ahead of the “Building Transparency and Accountability to Pharmacy Benefit Managers" hearing.